Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 80.4% in January

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 201,600 shares, a decline of 80.4% from the January 15th total of 1,030,000 shares. Based on an average daily volume of 3,070,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.7% of the shares of the stock are short sold.

Silo Pharma Price Performance

Shares of SILO stock traded down $0.02 during trading hours on Thursday, hitting $1.51. 133,944 shares of the company’s stock were exchanged, compared to its average volume of 6,362,240. Silo Pharma has a 52 week low of $0.77 and a 52 week high of $4.50. The stock’s 50-day moving average is $1.37 and its 200-day moving average is $1.26.

Silo Pharma (NASDAQ:SILO) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.22) EPS for the quarter. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%. The company had revenue of $0.02 million for the quarter.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.